AAVantgarde Bio is developing gene therapies for inherited retinal disorders. AAVantgarde Bio is an innovative biotech startup originating from research activities performed at Telethon Institute of Genetics and Medicine and backed by Sofinnova Partners.
Biotechnology, Therapeutics, Life Sciences
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as AAVantgarde Bio? We’re happy to assist you with our Startup Sourcing service.